Hap Trading, LLC Moon Lake Immunotherapeutics Transaction History
Hap Trading, LLC
- $1.15 Trillion
- Q4 2024
A detailed history of Hap Trading, LLC transactions in Moon Lake Immunotherapeutics stock. As of the latest transaction made, Hap Trading, LLC holds 20,000 shares of MLTX stock, worth $864,200. This represents 0.02% of its overall portfolio holdings.
Number of Shares
20,000Holding current value
$864,200% of portfolio
0.02%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding MLTX
# of Institutions
136Shares Held
60.6MCall Options Held
118KPut Options Held
89.7K-
Bvf Inc San Francisco, CA19.8MShares$853 Million39.28% of portfolio
-
Cormorant Asset Management, LP Boston, MA8.49MShares$367 Million35.64% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.34MShares$144 Million0.02% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.77MShares$120 Million2.15% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il2.19MShares$94.5 Million0.02% of portfolio
About MoonLake Immunotherapeutics
- Ticker MLTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,925,600
- Market Cap $1.6B
- Description
- MoonLake Immunotherapeutics, a clinical-stage biopharmaceutical company, engages in developing therapies. It is developing Sonelokimab, a novel investigational Nanobody therapy for the treatment of inflammation. The company is involved in conducting Phase II trials for hidradenitis suppurativa, psoriatic arthritis, ankylosing spondylitis, or rad...